CrystalO Biopharma

Shenzhen, China · Founded 2019 · Privately Held (backing)

Manufacturer of membrane protein drugs intended for neuropsychiatric disorders, chronic kidney disease and cardiovascular disease. CrystalO Biopharma is based in Shenzhen, China and was founded in 2019. It has raised $17.1 million.

Last price · $/share
—
Implied valuation
—
Total raised
$17.1M
Last round
—
How much has CrystalO Biopharma raised?
$17.1Macross 0 recorded rounds
Free account
More of CrystalO Biopharma with a free account
  • ·Watch CrystalO Biopharma: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

CrystalO Biopharma investors

9 investors are on record for CrystalO Biopharma, including Guangdong Technology Financial Group, Goldport Capital, Fuho Capital and HitGen.

For fundraisers
Raising for a company like CrystalO Biopharma?

9 investors have backed CrystalO Biopharma.

See all 9 investors →

Frequently asked about CrystalO Biopharma

How much has CrystalO Biopharma raised?
CrystalO Biopharma has raised $17.1M in total across 0 recorded funding rounds.